rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    IYH
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Defensive healthcare ETFs: broad funds, income options, and key caveats

      Investing.com -- Healthcare often acts as a shelter because people keep buying medicine and care in any economy. The screener (snapshot data, which may lag live prices) points to a few broad, low-cost US funds. Nasdaq-100 funds like Invesco QQQ Trust (QQQ) fell about 9% over 3 months. Healthcare funds gained roughly 10-12% over the same period.

      Nov 9Yahoo FinanceIHFIXJIYH
      IYH and XBI: Two Distinct Paths to Investing in Healthcare | The Motley Fool

      XBI delivered stronger 1-year returns at 45%, but IYH's diversified portfolio weathered volatility far better, with a maximum drawdown of just 17.9% versus 53.2%.

      Nov 7The Motley FoolIYHXBI
      Kalshi, Polymarket Put Democrats At 70%+: 5 ETFs To Watch - iShares Global Clean Energy ETF (NASDAQ:ICLN)
      Nov 2BenzingaITAICLNIHFIYH
      Healthcare ETF (IHF) Hits New 52-Week High
      Oct 23Yahoo FinanceIHFIYH
      Vanguard Health Care ETF vs iShares U.S. Healthcare ETF | The Motley Fool

      VHT's 411 holdings and 0.09% expense ratio deliver identical 5-year returns to IYH's concentrated 100-stock portfolio, raising questions about whether lower costs justify broader diversification.

      Oct 21The Motley FoolIYH
      Which iShares Healthcare ETF Is the Better Buy: Biotech-Focused IBB or Broad IYH? | The Motley Fool

      IBB has delivered stronger returns than IYH but with dramatically sharper swings in both directions. Here is how to decide which trade-off fits your portfolio.

      Oct 11The Motley FoolIBBIYH
      IYH Beats IXJ on Returns While Global Fund Offers Higher Yield | The Motley Fool

      U.S. healthcare stocks delivered 28.8% gains over one year versus 22.5% for international peers. Both funds carry nearly identical expense ratios and low volatility profiles.

      Oct 6The Motley FoolIXJIYH
      Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH | The Motley Fool

      IBBQ offers concentrated biotech exposure with lower costs and stronger recent returns, while IYH provides broader sector diversification and higher dividend income.

      Sep 23The Motley FoolIBBQIVZIYH
      Target, Truist Financial And More On CNBC’s ‘Final Trades’
      Sep 16BenzingaTFCTGTIYH
      iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy? | The Motley Fool

      Broad diversification and lower costs favor iShares, but Invesco's concentrated biotech bet delivered 47% returns in one year—at the cost of steeper drawdowns.

      Sep 10The Motley FoolIVZIYH
      Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026? | The Motley Fool

      IHE's concentrated pharma focus delivered 50% gains versus IYH's 27.4%, though the broader healthcare fund offers more diversification and $3.9B in assets.

      Sep 8The Motley FoolIYH
      Invesco Pharmaceuticals vs iShares Healthcare: Which Healthcare ETF Brings Better Profits | The Motley Fool

      Invesco's concentrated 30-stock pharma fund delivered 43.1% returns last year, but iShares' broader 100-holding portfolio costs less and offers wider sector exposure.

      Sep 8The Motley FoolIVZIYH

      This is the newest page. Registered accounts read further back.